Infrastructure for Cell Manufacturing
The Mytos Platform is infrastructure for fully automated manufacture of any human cell type
Customers include 2 of the Top 20 Pharma
The Mytos Platform fully automates manufacture of any human cell type
Cells are the Foundation of All New Medicines
For traditional drugs, cells are the testbed. For Cell Therapies, cells are the medicine.
Drug Discovery
$5B
40,000 machines worth of cell production across drug development
Cell Therapy
$20B
2 million patient cell batches a year by 2030
Mytos Platform is live with our Pharma customers
Q1 2019
Platform grows primary suspension cells
Q2 2021
Platform grows iPSCs - the hardest to grow human cell type
Q2 2022
Final pre-launch pilots
Q1 2023
Mytos Platform live with Pharma customers
Our Team
Bringing together some of the best hardware engineers, software engineers, and biologists to invent the infrastructure for biotech.
